Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation

Uptake of Talk About It (1)

Clinician report of number of times they utilized the Talk About It Tool in preceding 12 months

Time frame: At 18 months

Uptake of Talk About It (2)

Number of paper versions of Talk About It tool shared with patients each month as monitored by research staff

Time frame: At 6-18 months

Uptake of Talk About It (3)

Number of times the digital version of Talk About It is accessed for clinical care each month (webpage use monitoring software)

Time frame: At 6-18 months

Uptake of Talk About It (4)

Number of times patient reports using Talk About It on follow-up survey

Time frame: At 6-18 months

Medications for Opioid Use Disorder (MOUD) initiation

1. Rate of Methadone or buprenorphine started in ED (via EHR) 2. Rate of Prescription written for buprenorphine

Time frame: From 0-24 months

Recruitment: Clinician enrollment

Average number of eligible clinicians who complete training and survey instruments

Time frame: From 0-12 months

Recruitment: Patient enrollment

Average number of eligible patients who are enrolled each month

Time frame: From 0-24 months

Acceptability/Feasibility of Talk About It

The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Feasibility of Intervention Measure (FIM) scales are brief, validated scales that clinicians will answer regarding acceptability, appropriateness, and feasibility of the intervention. Trained clinicians will complete these scales twice (once immediately after training and once 12 months after training. Range 1-5 with higher meaning better

Time frame: At 6 and 18 months